Cargando…
In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antivirals
FKBP, a naturally occurring ubiquitous intracellular protein, has been proposed as a potential target for coronavirus replication. A non-immunosuppressive FKBP ligand, FK1706, was studied in vitro in a Vero cell model to assess potential activity alone and in combination with antivirals against SARS...
Autores principales: | Fitzsimmons, William E., Hartman, Tracy L., Mendenhall, Michelle, Chen, Catherine Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845424/ https://www.ncbi.nlm.nih.gov/pubmed/35169800 http://dx.doi.org/10.1101/2022.02.03.479080 |
Ejemplares similares
-
Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond
por: Rivera, Angela, et al.
Publicado: (2023) -
The effects of FK1706 on nerve regeneration and bladder function recovery following an end-to-side neurorrhaphy in rats
por: Gao, Wansheng, et al.
Publicado: (2017) -
Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52
por: Mustafi, Sourajit M., et al.
Publicado: (2014) -
An improved reversibly dimerizing mutant of the FK506-binding protein FKBP
por: Barrero, Juan J., et al.
Publicado: (2016) -
Identification of Tropoelastin as a Ligand for the 65-kD FK506-binding Protein, FKBP65, in the Secretory Pathway
por: Davis, Elaine C., et al.
Publicado: (1998)